181 related articles for article (PubMed ID: 21854712)
1. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
[TBL] [Abstract][Full Text] [Related]
4. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
[TBL] [Abstract][Full Text] [Related]
5. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of a prostate cancer radiation late toxicity questionnaire.
Rodrigues G; Bauman G; Lock M; D'Souza D; Mahon J
Health Qual Life Outcomes; 2007 May; 5():29. PubMed ID: 17540022
[TBL] [Abstract][Full Text] [Related]
7. Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.
Schroeck FR; Donatucci CF; Smathers EC; Sun L; Albala DM; Polascik TJ; Moul JW; Krupski TL
Cancer; 2008 Nov; 113(10):2687-94. PubMed ID: 18816628
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
[TBL] [Abstract][Full Text] [Related]
9. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
12. Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy.
Symon Z; Daignault S; Symon R; Dunn RL; Sanda MG; Sandler HM
Urology; 2006 Dec; 68(6):1224-9. PubMed ID: 17141840
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
15. Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer.
Haugnes HS; Melby B; Larsen KM; Langdal I; Rasi M; Bremnes RM
Scand J Urol Nephrol; 2012 Apr; 46(2):124-32. PubMed ID: 22352316
[TBL] [Abstract][Full Text] [Related]
16. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
[TBL] [Abstract][Full Text] [Related]
17. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
Muanza TM; Albert PS; Smith S; Godette D; Crouse NS; Cooley-Zgela T; Sciuto L; Camphausen K; Coleman CN; Ménard C
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1316-21. PubMed ID: 16029787
[TBL] [Abstract][Full Text] [Related]
18. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
[TBL] [Abstract][Full Text] [Related]
19. Early postoperative urinary and sexual function predicts functional recovery 1 year after prostatectomy.
Ellison JS; He C; Wood DP
J Urol; 2013 Oct; 190(4):1233-8. PubMed ID: 23608677
[TBL] [Abstract][Full Text] [Related]
20. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.
Dieperink KB; Hansen S; Wagner L; Johansen C; Andersen KK; Hansen O
Acta Oncol; 2012 Jul; 51(6):722-9. PubMed ID: 22793038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
